Incheon, South Korea

Se Il Lee

This inventor holds 1 USPTO granted patent. Top assignee: Sk Biopharmaceuticals Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Se Il Lee. Retrieved from https://idiyas.com/inventor/se-il-lee-kvm5jtgr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Se Il Lee: Innovator in Carbamic Acid Preparation

Introduction

Se Il Lee is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of chemistry, particularly in the preparation of carbamic acid derivatives. His innovative methods have the potential to impact various applications in pharmaceuticals and beyond.

Latest Patents

Se Il Lee holds a patent for a method for the preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester. This patent discloses a method that involves the asymmetric reduction of arylketone and the carbamation of alcohol. This innovative approach showcases his expertise in chemical synthesis and his commitment to advancing the field.

Career Highlights

Lee is currently associated with Sk Biopharmaceuticals Co., Ltd., where he continues to work on innovative solutions in biopharmaceuticals. His role at the company allows him to apply his knowledge and skills in a practical setting, contributing to the development of new therapeutic agents.

Collaborations

Se Il Lee has collaborated with notable colleagues, including Sang Chul Lim and Moo Yong Uhm. These partnerships highlight the collaborative nature of research and innovation in the field of biopharmaceuticals.

Conclusion

Se Il Lee is a distinguished inventor whose work in the preparation of carbamic acid derivatives exemplifies innovation in chemistry. His contributions are valuable to the advancement of biopharmaceuticals and demonstrate the importance of research and collaboration in scientific progress.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…